Boosting endogenous neuroprotection in multiple sclerosis: the ASsociation of Inosine and Interferon beta in relapsing- remitting Multiple Sclerosis (ASIIMS) trial.
about
Relating relapse and T2 lesion changes to disability progression in multiple sclerosis: a systematic literature review and regression analysisMultiple sclerosis: molecular mechanisms and therapeutic opportunitiesProtection by inosine in a cellular model of Parkinson's diseaseTreating gout with pegloticase, a PEGylated urate oxidase, provides insight into the importance of uric acid as an antioxidant in vivo.Low serum urate levels are associated to female gender in multiple sclerosis patients.The influence of nutritional factors on the prognosis of multiple sclerosis.Inosine to increase serum and cerebrospinal fluid urate in Parkinson disease: a randomized clinical trial.Failed, interrupted and inconclusive trials on relapsing multiple sclerosis treatment: update 2010-2015.Associated Inosine to interferon: results of a clinical trial in multiple sclerosis.Targeting urate to reduce oxidative stress in Parkinson disease.Association of serum bilirubin and uric acid levels changes during neuroinflammation in patients with initial and relapsed demyelination attacks.Influence of serum uric acid levels on prognosis and survival in amyotrophic lateral sclerosis: a meta-analysis
P2860
Q26828463-3FDA55C2-948B-4FFF-B454-0A4A160C04E0Q27023735-9612DCFB-9B7E-46BD-B9B0-CC33936A734EQ33998724-A05E83C6-703A-41BE-9238-391D27E0C5A2Q34069534-7E006CAE-042D-4928-BC46-5281DC8DB06AQ34357957-121AC89B-4F11-4403-B6B2-07038DD81E2AQ34643392-87002FE0-DE18-4F90-B086-373E3B525B2CQ34658560-F39F3E7A-60CC-4F75-8972-2D95D616394CQ38801807-B540A827-5429-40DE-A9C9-2B7C1398E920Q39113644-5348A2D9-7AA2-4639-A02B-7EB1878CDE3DQ39379023-0D0E8E4B-E8E1-48F4-A94E-DE0C3E1FF71CQ42265779-9087824C-906B-41F1-B6C6-8A2928BEF700Q57176144-D71BB74B-3CD5-4A5C-82D8-B8B06FEDD728
P2860
Boosting endogenous neuroprotection in multiple sclerosis: the ASsociation of Inosine and Interferon beta in relapsing- remitting Multiple Sclerosis (ASIIMS) trial.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Boosting endogenous neuroprote ...... iple Sclerosis (ASIIMS) trial.
@ast
Boosting endogenous neuroprote ...... iple Sclerosis (ASIIMS) trial.
@en
Boosting endogenous neuroprote ...... - remitting Multiple Sclerosis
@nl
type
label
Boosting endogenous neuroprote ...... iple Sclerosis (ASIIMS) trial.
@ast
Boosting endogenous neuroprote ...... iple Sclerosis (ASIIMS) trial.
@en
Boosting endogenous neuroprote ...... - remitting Multiple Sclerosis
@nl
prefLabel
Boosting endogenous neuroprote ...... iple Sclerosis (ASIIMS) trial.
@ast
Boosting endogenous neuroprote ...... iple Sclerosis (ASIIMS) trial.
@en
Boosting endogenous neuroprote ...... - remitting Multiple Sclerosis
@nl
P2093
P2860
P356
P1476
Boosting endogenous neuroprote ...... iple Sclerosis (ASIIMS) trial.
@en
P2093
ASIIMS study group
Alex Michotte
Christian Sindic
Daniel Guillaume
Peter-Paul De Deyn
Pierrette Seeldrayers
Richard E Gonsette
Robert Medaer
P2860
P304
P356
10.1177/1352458509360547
P577
2010-03-03T00:00:00Z